Tag
Scientists used AI and lab-grown brain organoids to create the largest molecular map of autism, uncovering over 1,800 protein-protein interactions that could inform new targeted therapies.
The FDA has approved Rasonque (daraxonrasib), a first-in-class RAS inhibitor, for the treatment of metastatic pancreatic cancer, demonstrating improved overall survival in clinical trials.
A standing ovation greeted the full results of Daraxonrasib, a targeted therapy for pancreatic cancer, marking a major breakthrough. The researcher expresses inspiration that nothing is undruggable anymore.